Zerone Cellvane Receives Major Award at 19th Korea Best Brand Awards

Zerone Cellvane, a company contributing to creating a healthier society, received the Best Brand Grand Prize at the 19th Korea Best Brand Awards held on December 1 by the Korea Best Brand Association at the Grand Conference Room in Yeouido.

Zerone Cellvane is a pharmaceutical company that uses 'PDRN' (polydeoxyribonucleotide) as its main product, specifically 'Cellvane Injection', which is used to treat pain and inflammation.

PDRN (polydeoxyribonucleotide) is extracted from salmon sperm and testicles and is used as a medical drug or equipment. Anatomically, it consists of more than 90% DNA-like substances. It affects tissue formation and is used in various fields. Recently, it has gained attention in dentistry due to its minimal surgical requirements and is used to treat periodontitis and dental implants.

Seong Si-jong, Vice President of Zerone Cellvane, who attended today's market opening ceremony, said, "Zerone Cellvane has established itself as Korea's PDRN brand company. We plan to develop technology that can be used as a treatment for various inflammatory conditions and launch it next year. We are committed to creating a healthy society and becoming a growing company."

At today's award ceremony, Lee Yoon-tae, Chairman of the Korea Best Brand Association, Heo Shin-haeng, the 44th former Minister of Agriculture, Forestry and Fisheries, Chairman Gwang-sik, Chairman of the National Strategy Planning Institute, and others were in attendance.

Posting time 01-December-2023
Information from Naver Website: https://www.pharmnews.com/news/articleView.html?idxno=235780